{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T10:34:41Z","timestamp":1716287681110},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s10165-011-0471-2","type":"journal-article","created":{"date-parts":[[2011,6,8]],"date-time":"2011-06-08T20:57:16Z","timestamp":1307566636000},"page":"73-79","source":"Crossref","is-referenced-by-count":3,"title":["High circulating levels of interleukin-18 binding protein indicate the severity of glomerular involvement in systemic lupus erythematosus"],"prefix":"10.1093","volume":"22","author":[{"given":"Chie","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Fuke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Satomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Soma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,6,9]]},"reference":[{"key":"471_CR1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF00197516","volume":"16","author":"DA Horwitz","year":"1994","unstructured":"Horwitz DA, Jacob CO. The cytokine network in the pathogenesis of systemic lupus erythematosus and possible therapeutic implications. Springer Semin Immunopathol. 1994;16:181\u2013200.","journal-title":"Springer Semin Immunopathol"},{"key":"471_CR2","first-page":"1473","volume":"35","author":"M Aringer","year":"2008","unstructured":"Aringer M, Crow MK. A bridge between interferon-alpha and tumor necrosis factor in lupus. J Rheumatol. 2008;35:1473\u20136.","journal-title":"J Rheumatol"},{"key":"471_CR3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/ard.59.4.243","volume":"59","author":"GS Dean","year":"2000","unstructured":"Dean GS, Tyrrell-Price J, Crawley E, Isenberg DA. Cytokines and systemic lupus erythematosus. Ann Rheum Dis. 2000;59:243\u201351.","journal-title":"Ann Rheum Dis"},{"key":"471_CR4","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.4049\/jimmunol.167.9.5338","volume":"167","author":"E Esfandiari","year":"2001","unstructured":"Esfandiari E, McInnes IB, Lindop G, Huang FP, Field M, Komai-Koma M, Wei X, Liew FY. A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease. J Immunol. 2001;167:5338\u201347.","journal-title":"J Immunol"},{"key":"471_CR5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/378088a0","volume":"378","author":"H Okamura","year":"1995","unstructured":"Okamura H, Tsutsui H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, Akita K, Namba M, Tanabe F, KOonishi K, Fukuda S, Kurimoto M. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature. 1995;378:88\u201391.","journal-title":"Nature"},{"key":"471_CR6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0952-7915(98)80163-5","volume":"10","author":"H Okamura","year":"1998","unstructured":"Okamura H, Kashiwamura S, Tsutsui H, Yoshimoto T, Nakanishi K. Regulation of interferon-gamma production by IL-12 and IL-18. Curr Opin Immunol. 1998;10:259\u201364.","journal-title":"Curr Opin Immunol"},{"key":"471_CR7","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/rheumatology\/39.10.1078","volume":"39","author":"CK Wong","year":"2000","unstructured":"Wong CK, Li EK, Ho CY, Lam CW. Elevation of plasma interleukin-18 concentration is correlated with disease activity in systemic lupus erythematosus. Rheumatology (Oxf). 2000;39:1078\u201381.","journal-title":"Rheumatology (Oxf)"},{"key":"471_CR8","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0014-5793(99)00148-9","volume":"445","author":"Y Aizawa","year":"1999","unstructured":"Aizawa Y, Akita K, Taniai M, Torigoe K, Mori T, Nishida Y, Ushio S, Nukada Y, Tanimoto T, Ikegami H, Ikeda M, Kurimoto M. Cloning and expression of interleukin-18 binding protein. FEBS Lett. 1999;445:338\u201342.","journal-title":"FEBS Lett"},{"key":"471_CR9","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1073\/pnas.97.3.1190","volume":"97","author":"SH Kim","year":"2000","unstructured":"Kim SH, Eisenstein M, Reznikov L, Fantuzzi G, Novick D, Rubinstein M, Dinarello CA. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc Natl Acad Sci USA. 2000;97:1190\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"471_CR10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/cyto.2001.0914","volume":"14","author":"D Novick","year":"2001","unstructured":"Novick D, Schwartsburd B, Pinkus R, Suissa D, Belzer I, Sthoeger Z, Keane WF, Chvatchko Y, Kim SH, Fantuzzi G, Dinarello CA, Rubinstein M. A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. Cytokine. 2001;14:334\u201342.","journal-title":"Cytokine"},{"key":"471_CR11","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.2337\/diacare.28.12.2890","volume":"28","author":"A Nakamura","year":"2005","unstructured":"Nakamura A, Shikata K, Hiramatsu M, Nakatou T, Kitamura T, Wada J, Itoshima T, Makino H. Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes. Diabetes Care. 2005;28:2890\u20135.","journal-title":"Diabetes Care"},{"key":"471_CR12","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0002-9343(83)90338-8","volume":"75","author":"HA Austin 3rd","year":"1983","unstructured":"Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH, Decker JL, Balow JE. Prognostic factors in lupus nephritis: contribution of renal histologic data. Am J Med. 1983;75:382\u201391.","journal-title":"Am J Med"},{"key":"471_CR13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1523-1755.2004.00443.x","volume":"65","author":"JJ Weening","year":"2004","unstructured":"Weening JJ, D\u2019Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA. Nagata M; International Society of Nephrology Working Group on the Classification of Lupus Nephritis; Renal Pathology Society Working Group on the Classification of Lupus Nephritis. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65:521\u201330.","journal-title":"Kidney Int"},{"key":"471_CR14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/art.23186","volume":"58","author":"M Tucci","year":"2008","unstructured":"Tucci M, Quatraro C, Lombardi L, Pellegrino C, Dammacco F, Silvestris F. Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18. Arthritis Rheum. 2008;58:251\u201362.","journal-title":"Arthritis Rheum"},{"key":"471_CR15","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271\u20137.","journal-title":"Arthritis Rheum"},{"key":"471_CR16","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum. 1992;35:630\u201340.","journal-title":"Arthritis Rheum"},{"key":"471_CR17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-1759(97)00164-6","volume":"209","author":"K Konishi","year":"1997","unstructured":"Konishi K, Tanabe F, Taniguchi M, Yamauchi H, Tanimoto T, Ikeda M, Orita K, Kurimoto M. A simple and sensitive bioassay for the detection of human interleukin-18\/interferon-gamma-inducing factor using human myelomonocytic KG-1 cells. J Immunol Methods. 1997;209:187\u201391.","journal-title":"J Immunol Methods"},{"key":"471_CR18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1365-2249.2002.01989.x","volume":"130","author":"CK Wong","year":"2002","unstructured":"Wong CK, Ho CY, Li EK, Tam LS, Lam CW. Elevated production of interleukin-18 is associated with renal disease in patients with systemic lupus erythematosus. Clin Exp Immunol. 2002;130:345\u201351.","journal-title":"Clin Exp Immunol"},{"key":"471_CR19","unstructured":"Fujita T, Shimizu C, Fuke Y, Satomura A, Abe M, Kaizu K, Matsumoto K, Soma M. Serum interleukin-18 binding protein increases with behavior different from IL-18 in patients with diabetic nephropathy. Diabetes Res Clin Pract. 2011;Mar 25 [Epub ahead of print]."},{"key":"471_CR20","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/jcp.21348","volume":"215","author":"VS Reddy","year":"2008","unstructured":"Reddy VS, Harskamp RE, van Ginkel MW, Calhoon J, Baisden CE, Kim IS, Valente AJ, Chandrasekar B. Interleukin-18 stimulates fibronectin expression in primary human cardiac fibroblasts via PI3\u00a0K-Akt-dependent NF-kappa B activation. J Cell Physiol. 2008;215:697\u2013707.","journal-title":"J Cell Physiol"},{"issue":"Suppl 3","key":"471_CR21","first-page":"iii18","volume":"60","author":"CA Dinarello","year":"2001","unstructured":"Dinarello CA. Novel targets for interleukin 18 binding protein. Ann Rheum Dis. 2001;60(Suppl 3):iii18\u201324.","journal-title":"Ann Rheum Dis"},{"key":"471_CR22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/ki.2008.99","volume":"74","author":"S Segerer","year":"2008","unstructured":"Segerer S, Heller F, Lindenmeyer MT, Schmid H, Cohen CD, Draganovici D, Mandelbaum J, Nelson PJ, Gr\u00f6ne HJ, Gr\u00f6ne EF, Figel AM, N\u00f6ssner E, Schl\u00f6ndorff D. Compartment specific expression of dendritic cell markers in human glomerulonephritis. Kidney Int. 2008;74:37\u201346.","journal-title":"Kidney Int"},{"key":"471_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10157-009-0218-y","volume":"14","author":"K Matsumoto","year":"2010","unstructured":"Matsumoto K, Fukuda N, Abe M, Fujita T. Dendritic cells and macrophages in kidney disease. Clin Exp Nephrol. 2010;14:1\u201311.","journal-title":"Clin Exp Nephrol"},{"key":"471_CR24","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1002\/eji.200323864","volume":"33","author":"F Nicoletti","year":"2003","unstructured":"Nicoletti F, Di Marco R, Papaccio G, Conget I, Gomis R, Bernardini R, Shoenfeld Y, Bendtzen K. Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: Fc construct. Eur J Immunol. 2003;33:2278\u201386.","journal-title":"Eur J Immunol"},{"key":"471_CR25","first-page":"303","volume":"3","author":"D Liang","year":"2006","unstructured":"Liang D, Ma W, Yao C, Liu H, Chen X. Imbalance of interleukin 18 and interleukin 18 binding protein in patients with lupus nephritis. Cell Mol Immunol. 2006;3:303\u20136.","journal-title":"Cell Mol Immunol"},{"key":"471_CR26","unstructured":"Leng J, Yao H, Shen J, Wang K, Zhuo G, Wang Z. Co-expression of IL-18 binding protein and IL-4 regulates Th1\/Th2 cytokine response in murine collagen-induced arthritis. Acta Biochim Biophys Sin (Shanghai). 2008;40:116\u201324."},{"key":"471_CR27","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood-2005-05-1980","volume":"106","author":"K Mazodier","year":"2005","unstructured":"Mazodier K, Marin V, Novick D, Farnarier C, Robitail S, Schleinitz N, Veit V, Paul P, Rubinstein M, Dinarello CA, Harl\u00e9 JR, Kaplanski G. Severe imbalance of IL-18\/IL-18BP in patients with secondary hemophagocytic syndrome. Blood. 2005;106:3483\u20139.","journal-title":"Blood"},{"key":"471_CR28","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1086\/650314","volume":"201","author":"A Iannello","year":"2010","unstructured":"Iannello A, Boulassel MR, Samarani S, Tremblay C, Toma E, Routy JP, Ahmad A. HIV-1 causes an imbalance in the production of interleukin-18 and its natural antagonist in HIV-infected individuals: implications for enhanced viral replication. J Infect Dis. 2010;201:608\u201317.","journal-title":"J Infect Dis"},{"key":"471_CR29","unstructured":"Fujita T, Ogihara N, Kamura Y, Satomura A, Fuke Y, Shimizu C. Wada Y, Matsumoto K. Interleukin-18 contributes more closely to the progression of diabetic nephropathy than other diabetic complications. Acta Diabetol. 2010; Feb 26 [E-pub ahead of print]."},{"key":"471_CR30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/0267659108101511","volume":"23","author":"A Platis","year":"2008","unstructured":"Platis A, Yu Q, Moore D, Khojeini E, Tsau P, Larson D. The effect of daily administration of IL-18 on cardiac structure and function. Perfusion. 2008;23:237\u201342.","journal-title":"Perfusion"},{"issue":"Suppl 3","key":"471_CR31","first-page":"25","volume":"86","author":"KT Weber","year":"1991","unstructured":"Weber KT, Brilla CG, Janicki JS, Reddy HK, Campbell SE. Myocardial fibrosis: role of ventricular systolic pressure, arterial hypertension, and circulating hormones. Basic Res Cardiol. 1991;86(Suppl 3):25\u201331.","journal-title":"Basic Res Cardiol"},{"key":"471_CR32","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2215\/CJN.09061209","volume":"5","author":"ED Siew","year":"2010","unstructured":"Siew ED, Ikizler TA, Gebretsadik T, Shintani A, Wickersham N, Bossert F, Peterson JF, Parikh CR, May AK, Ware LB. Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomes. Clin J Am Soc Nephrol. 2010;5:1497\u2013505.","journal-title":"Clin J Am Soc Nephrol"},{"key":"471_CR33","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.2215\/CJN.01910310","volume":"5","author":"CC Szeto","year":"2010","unstructured":"Szeto CC, Kwan BC, Lai KB, Lai FM, Chow KM, Wang G, Luk CC, Li PK. Urinary expression of kidney injury markers in renal transplant recipients. Clin J Am Soc Nephrol. 2010;5:2329\u201337.","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10165-011-0471-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:25:21Z","timestamp":1646843121000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-011-0471-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,9]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["471"],"URL":"https:\/\/doi.org\/10.1007\/s10165-011-0471-2","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,9]]}}}